Objective-To examine whether a lack of prostaglandin E receptor 4 (EP4) on bone marrow-derived cells would increase local inflammation and enhance the formation of abdominal aortic aneurysm (AAA) in vivo.
A bdominal aortic aneurysms (AAAs) exhibit characteristics of a chronic inflammatory disorder. [1] [2] [3] Although much work has focused on proinflammatory pathways participating in the pathogenesis of AAA, knowledge has lagged regarding the role of endogenous anti-inflammatory pathways in this condition. Microsomal prostaglandin E 2 (PGE 2 ) synthase-1 (mPGES-1), which catalyzes isomerization of the cyclooxygenase product endoperoxide, produces PGE 2 . PGE 2 predominately acts on 4 receptors (ie, EP1, EP2, EP3, and EP4). 4 Human AAA tissues display increased biosynthesis of PGE 2 . [5] [6] [7] Mouse and human AAA tissues express abundant EP4. 8, 9 Studies using mPGES-1-deficient mice have shown suppressed formation of angiotensin (Ang) II-induced AAA. 7 These studies support a role for mPGES-1, PGE 2 release, and EPs in the pathogenesis of AAA. PGE 2 , through EP4, suppresses the production of inflammatory cytokines (including tumor necrosis factor-␣, inter-leukin [IL]-12, and interferon-␥) and chemokines (including monocyte chemoattractant protein [MCP]-1, macrophage inflammatory proteins [MIPs] , such as MIP-1␣ and MIP-1␤, interferon-␥-inducible protein-10, and IL-8) in macrophages in vitro. 10 -12 All of these molecules can participate in leukocyte recruitment to AAA lesions. Thus, the activation of EP4 may constitute a key endogenous anti-inflammatory pathway. Recent studies have illustrated that an EP4 agonist prolonged cardiac allograft survival 13 and improved cardiac function after myocardial ischemia reperfusion injury in rodents by reducing inflammation. 14, 15 The cardioprotective effects exerted by EP4 agonists render them potentially novel approaches to the treatment or prevention of inflammatory disorders of the cardiovascular system. AAA lesions commonly exhibit loss of elastin, believed to result from the actions of enzymes such as matrix metalloproteinases (MMPs) and certain elastolytic cathepsins. PGE 2 , through EP4 ligation, can increase the expression of MMP-2 and MMP-9 in cultured monocytes and macrophages. 16 -18 Another study 19 showed that PGE 2 decreased MMP-9 in peritoneal macrophages from patients with endometriosis in vitro. Moreover, PGE 2 influences cell apoptosis, another important component of AAA development. Studies show that EP4 agonism limits macrophage apoptosis, whereas deficiency of the receptor augments this process. 20 Thus, EP4 plays a role in many of the mechanisms implicated in AAA formation.
Screening studies 21, 22 have shown that 4% to 5% of men Ͼ60 years have small AAAs. Even in these small aneurysms, the inflammatory process appears well established. 23, 24 Most of these small AAAs continue to expand and can cause substantial morbidity and mortality. No therapeutic approach can prevent AAA, leaving patients with invasive treatments as their only option. Accordingly, chemopreventive strategies to prevent the expansion of AAA have considerable appeal.
The importance of EP4 in the pathogenesis of AAA is unknown. We tested the hypothesis that the lack of EP4 on bone marrow-derived cells would increase local inflammation and enhance the formation of experimental aneurysms in vivo.
Methods
Hypercholesterolemic low-density lipoprotein receptor knockout (LDLR Ϫ/Ϫ ) mice transplanted with either EP4 ϩ/ϩ or EP4 Ϫ/Ϫ bone marrow received infusions of angiotensin II to induce AAA. EP4 ϩ/ϩ and EP4 Ϫ/Ϫ bone marrow chimera will be referred to as EP4 ϩ/ϩ / LDLR Ϫ/Ϫ and EP4 Ϫ/Ϫ /LDLR Ϫ/Ϫ , respectively, throughout the article. The supplemental materials (available online at http://atvb. ahajournals.org) provide detailed methods.
Results
Congenic C57BL/6 LDLR Ϫ/Ϫ mice that received transplants from bone marrow of EP4 ϩ/ϩ or EP4 Ϫ/Ϫ mice appeared healthy. The meanϮSD body weights for female EP4 ϩ/ϩ / LDLR Ϫ/Ϫ mice and female EP4 Ϫ/Ϫ /LDLR Ϫ/Ϫ mice (nϭ8 -12) at tissue harvest were 21.08Ϯ2.21 g and 21.74Ϯ1.89 g, respectively. The meanϮSD body weights for male EP4 ϩ/ϩ / LDLR Ϫ/Ϫ mice and male EP4 Ϫ/Ϫ /LDLR Ϫ/Ϫ mice (nϭ8 -12) at tissue harvest were 21.50Ϯ2.00 g and 22.60ϩ1.80 g, respectively. The body weights of wild-type chimeric mice were not significantly different from those of knockout chimeric mice.
Survival rates were comparable between the experimental groups. During the 4 weeks of Ang II infusion, there were no deaths in the male EP4 ϩ/ϩ /LDLR Ϫ/Ϫ group, whereas 1 male EP4 Ϫ/Ϫ /LDLR Ϫ/Ϫ mouse died. In the female group, there was 1 death for each mouse genotype. All of these deaths occurred within the first week of Ang II infusion. These deaths were not associated with aneurysmal rupture, as qualified by the absence of AAA on dissection; therefore, the aortas of these deceased mice were not used in subsequent analysis.
The infusion of Ang II for 4 weeks significantly increased mean arterial blood pressure in high-fat-fed EP4 ϩ/ϩ / LDLR Ϫ/Ϫ and EP4 Ϫ/Ϫ /LDLR Ϫ/Ϫ mice (blood pressure at week 0 versus week 4; PϽ0.01; Figure 1A and 1B). There was no significant difference between the blood pressures of male EP4 ϩ/ϩ /LDLR Ϫ/Ϫ mice and male EP4 Ϫ/Ϫ /LDLR Ϫ/Ϫ mice when the entire blood pressure curve was compared by area under the curve. Interestingly, for the male mice, the blood pressure of EP4 ϩ/ϩ /LDLR Ϫ/Ϫ mice appeared to be lower than that of EP4 Ϫ/Ϫ /LDLR Ϫ/Ϫ mice at week 3. However, a comparison with the nonparametric Mann-Whitney U test at this point (EP4 ϩ/ϩ /LDLR Ϫ/Ϫ versus EP4 Ϫ/Ϫ / LDLR Ϫ/Ϫ mice at 3 weeks) revealed no statistical significance (Pϭ0.0645). For the female group, there was no significant difference regarding whether the blood pressure data of EP4 ϩ/ϩ /LDLR Ϫ/Ϫ mice and EP4 Ϫ/Ϫ /LDLR Ϫ/Ϫ mice were compared by area under the curve or week by week (point by point during the 4 separate points, Figure 1B ).
The infusion of Ang II yielded aneurysms in the abdominal aorta differently, depending on the donor cell genotype. EP4 ϩ/ϩ /LDLR Ϫ/Ϫ mice had a lower incidence of Ang IIinduced AAA compared with EP4 Ϫ/Ϫ /LDLR Ϫ/Ϫ mice, in both male and female mice ( Figure 1C ). In male mice, the prevalence of AAA was 50% for EP4 ϩ/ϩ /LDLR Ϫ/Ϫ and 88.9% for EP4 Ϫ/Ϫ /LDLR Ϫ/Ϫ . In female mice, the prevalence of AAA was 22% for EP4 ϩ/ϩ /LDLR Ϫ/Ϫ and 83.3% for EP4 Ϫ/Ϫ /LDLR Ϫ/Ϫ . The 5-level classification scheme described in the supplementary material characterized the complexity of the aneurysms formed. Among males, many EP4 ϩ/ϩ /LDLR Ϫ/Ϫ mice did not develop aneurysms, whereas most aneurysms in EP4 Ϫ/Ϫ /LDLR Ϫ/Ϫ mice were in class 1 or 2 ( Figure 1E ). Similarly, for females, many EP4 ϩ/ϩ / LDLR Ϫ/Ϫ mice did not develop observable aneurysms, whereas most aneurysms in EP4 Ϫ/Ϫ /LDLR Ϫ/Ϫ mice were in class 1 ( Figure 1F ). All aneurysms formed at the suprarenal region of the aorta. The diameters of the suprarenal aortas in both male and female EP4 Ϫ/Ϫ /LDLR Ϫ/Ϫ mice were wider, on average, than their EP4 ϩ/ϩ /LDLR Ϫ/Ϫ counterparts ( Figure  1D ). Overall, deletion of EP4 on bone marrow-derived cells increased the incidence and severity of experimental aneurysms.
Cross-sectioning of the suprarenal region of the aorta revealed perimedial remodeling in many mice that visual inspection could not identify. EP4 Ϫ/Ϫ /LDLR Ϫ/Ϫ mice had a greater maximal intimal-medial thickness (as measured by the maximal distance from the periphery to the closest part of the lumen on a particular aneurysm section, Figure 2A -C), a greater outer perimeter of the aneurysm section ( Figure 2D ), and a larger aneurysmal lesion area ( Figure 2E ) compared with EP4 ϩ/ϩ /LDLR Ϫ/Ϫ mice. This pattern applied to both male and female mice. The 0-to-4 scale described in the supplementary material graded the degree of elastin fragmentation on AAA lesions among different experimental groups ( Figure 2G ). In the overall comparison, in which sections were included regardless of AAA grade, the aneurysm lesions of EP4 Ϫ/Ϫ /LDLR Ϫ/Ϫ mice had greater elastin fragmentation than those from EP4 ϩ/ϩ /LDLR Ϫ/Ϫ mice ( Figure 2F ). Furthermore, when the aneurysm lesions of the same grade were compared, EP4 Ϫ/Ϫ /LDLR Ϫ/Ϫ mice had enhanced MMP and cathepsin elastolytic activity (nϭ3-4, Figure 3 ).
The deletion of EP4 on bone marrow cells increased the number of cells positive for mac-3 (a marker for macrophages, Figure 4A and 4F) and for CD4 (a marker for T cells, Figure 4B and 4G) in AAA lesions. The percentage of mac-3-positive area on aneurysmal lesions of EP4 Ϫ/Ϫ / LDLR Ϫ/Ϫ mice increased significantly, by 2.72-fold in male mice and by 1.64-fold in female mice, compared with EP4 ϩ/ϩ /LDLR Ϫ/Ϫ mice. The amount of T cells in lesions of EP4 Ϫ/Ϫ /LDLR Ϫ/Ϫ mice increased significantly, by 1.88-fold in male mice and by 1.66-fold in female mice, compared with EP4 ϩ/ϩ /LDLR Ϫ/Ϫ mice. In addition, the lack of EP4 on bone marrow-derived cells increased expression of MCP-1 in the aneurysm lesions ( Figure 4C Figure 4 illustrates entire group comparisons: mac-3, CD4, MCP-1, ␣-smooth muscle, and TUNEL staining on sections. All grades of aneurysm lesion were included.
In addition to overall group-to-group comparison, in which sections from all grades of aneurysm lesions were included and analyzed, we compared statistically aneurysms of the same grade between groups. This approach enabled us to segregate whether changes in the parameters studied were mere consequences of an increased incidence of AAA or direct changes on localized inflammation caused by the absence of EP4 on immune cells. In the male group, 3 of 8 AAAs in EP4 ϩ/ϩ /LDLR Ϫ/Ϫ mice were grade 1, and 4 of 9 EP4 Ϫ/Ϫ /LDLR Ϫ/Ϫ mice had the same grade. In the female group, 2 of 9 EP4 ϩ/ϩ /LDLR Ϫ/Ϫ mice had type 2 AAAs, and only 1 of 12 EP4 Ϫ/Ϫ /LDLR Ϫ/Ϫ mice had the same grade. As there were few sections of the same grade in female mice, comparison of AAAs of the same grade between groups was performed using sections from male mice only. Mac-3, CD4, MCP-1, ␣-smooth muscle, TUNEL staining, and elastin grade on type 1 AAA sections of EP4 ϩ/ϩ /LDLR Ϫ/Ϫ mice were compared with type 1 AAA sections of EP4 Ϫ/Ϫ / LDLR Ϫ/Ϫ mice ( Figure 5A ). Despite the low number of type 1 aneurysm lesions in male mice (nϭ3-4), the amount of mac-3 (Pϭ0.0183), CD4 (Pϭ0.0067), and MCP-1 (Pϭ0.0468) staining on type 1 aneurysm lesions of EP4 Ϫ/Ϫ / LDLR Ϫ/Ϫ mice was significantly greater than that found in type 1 aneurysm lesions of wild-type chimeric mice. Type 1 aneurysm lesions in EP4 Ϫ/Ϫ /LDLR Ϫ/Ϫ mice had significantly fewer ␣-actin-positive cells than their wild-type counterparts (Pϭ0.0392). The amount of apoptotic cells appeared greater in EP4 Ϫ/Ϫ /LDLR Ϫ/Ϫ mice compared with wild-type chimeric mice, but this did not reach statistical significance (which may be because of the small number of lesions [nϭ3-4], the small effect size, or both). The degree of elastin fragmenta- *PϽ0.05 vs week 0. C and D, The absence of EP4 on bone marrowderived cells enhanced the incidence of AAA formation (C) and increased the severity of disease, as reflected by an increase in the suprarenal aortic diameter (D). E and F, Distribution of aneurysm formation into each AAA category for male (E) and female (F) mice. (Type 0 indicates no aneurysm; type 1, suprarenal dilation of 50% increase in aortic diameter without thrombus; type 2, suprarenal dilation of 50% increase in aortic diameter with thrombus; type 3, multiple aneurysms, including thoracic aneurysms and dissections; and type 4, death due to aneurysmal rupture.) The number of mice within each category is indicated at the top of the bar. Values are expressed as meanϮSD.
tion between type 1 lesions of EP4 ϩ/ϩ /LDLR Ϫ/Ϫ mice and EP4 Ϫ/Ϫ /LDLR Ϫ/Ϫ mice was not significantly different (Figure 5A) . Thus, the increase in mac-3, CD4, MCP-1, and apoptotic cell staining and the decrease in ␣-smooth muscle in aneurysmal lesions of EP4 Ϫ/Ϫ /LDLR Ϫ/Ϫ mice appear to be directly linked to the absence of EP4 on bone marrowderived cells. The enhanced elastin fragmentation in EP4 Ϫ/Ϫ / LDLR Ϫ/Ϫ mice, however, observed when sections from all grades of aneurysm lesions were averaged, appears to be a mere consequence, rather than a direct effect, of an increase in AAA incidence in the knockout group.
To consolidate our data further, we performed RT-PCR experiments using suprarenal segments of the aorta in which an aneurysm occurred (aortas from all mice regardless of AAA type were used for the RT-PCR experiment, Figure  5B ). The mRNA expression of CD3 (a marker for T cells), CD68 (a marker for macrophages), and MCP-1 increased significantly in the aortas of EP4 Ϫ/Ϫ /LDLR Ϫ/Ϫ mice compared with EP4 ϩ/ϩ /LDLR Ϫ/Ϫ mice (both male and female). A comparison of aneurysms of the same grade among groups showed significantly higher mRNA expression of CD3, CD68, and MCP-1 in the aortas of EP4 Ϫ/Ϫ /LDLR Ϫ/Ϫ mice compared with EP4 ϩ/ϩ /LDLR Ϫ/Ϫ mice, despite the small sample size (data not shown, nϭ3-4).
Deletion of EP4 on bone marrow-derived cells increased the amount of lipid in the thoracic aorta, as reflected by the Figure 6 ). The lack of EP4 on bone marrow-derived cells in mice infused with Ang II produced increased levels of nonfasting plasma triglycerides and total cholesterol ( Figure 6 ). But in the absence of Ang II infusion, there was no difference in plasma lipids between EP4 ϩ/ϩ /LDLR Ϫ/Ϫ mice and EP4 Ϫ/Ϫ /LDLR Ϫ/Ϫ mice. The meanϮSD plasma cholesterol levels in the female EP4 ϩ/ϩ / LDLR Ϫ/Ϫ mice and the female EP4 Ϫ/Ϫ /LDLR Ϫ/Ϫ mice (high-fat fed for 5 weeks, without Ang II infusion) were 639Ϯ176 and 758Ϯ367 mg/dL, respectively. The meanϮSD plasma triglyceride levels in the female EP4 ϩ/ϩ /LDLR Ϫ/Ϫ mice and the female EP4 Ϫ/Ϫ /LDLR Ϫ/Ϫ mice (high-fat fed for 5 weeks, without Ang II infusion) were 208Ϯ50 and 244Ϯ96 mg/dL, respectively (nϭ5).
Discussion
Our study demonstrates that mice deficient in EP4 on bone marrow-derived cells have accentuated aneurysm development compared with wild-type mice. Because PGE 2 suppresses the production of chemokines, such as MCP-1, in human macrophages through EP4 in vitro, 12 we tested whether the greater incidence and severity of AAAs observed in EP4 Ϫ/Ϫ /LDLR Ϫ/Ϫ mice were associated with elevated MCP-1. Indeed, the expression of MCP-1 in AAA lesions of EP4 Ϫ/Ϫ /LDLR Ϫ/Ϫ mice increased 3.79-fold in male mice and 2.44-fold in female mice, compared with EP4 ϩ/ϩ /LDLR Ϫ/Ϫ mice. MCP-1 promotes the recruitment of inflammatory cells, and the aneurysm lesions of EP4-deficient bone marrow chimeric mice had markedly increased accumulation of macrophages and T cells, signifying an escalation of local inflammation. The mRNA expression data agree with the histological data. Moreover, comparisons between aneurysms of the same grade showed greater levels of macrophages, T cells, and MCP-1 in aneurysm lesions of EP4 Ϫ/Ϫ /LDLR Ϫ/Ϫ mice, indicating that these changes result from the lack of EP4 on bone marrow-derived cells.
In an overall group-to-group comparison, comparing aneurysms of the same grade, the aneurysm lesions of EP4 Ϫ/Ϫ / LDLR Ϫ/Ϫ mice had fewer SMCs than those of EP4 ϩ/ϩ / LDLR Ϫ/Ϫ mice. SMCs constitute a major source of elastin and collagen and, thus, contribute to repair and maintenance of the arterial extracellular matrix. Depletion of SMCs may weaken the media and favor aneurysm formation. In addition, aneurysm lesions of EP4 Ϫ/Ϫ /LDLR Ϫ/Ϫ mice showed more apoptotic cells than EP4 ϩ/ϩ /LDLR Ϫ/Ϫ mice in overall groupto-group comparison and a similar propensity when aneurysms of the same grade were compared. This observation corresponds with a recent study 20 showing that EP4 deficiency increases apoptosis in mouse atheromata. SMC loss due to apoptosis may cause accelerated AAA lesion formation in EP4 Ϫ/Ϫ /LDLR Ϫ/Ϫ mice.
The infiltration of monocytes and macrophages into the vessel wall presents a major source of proteolytic enzymes, including MMPs and cathepsins, which promote matrix degradation, thus impairing the integrity of the artery wall and favoring aneurysm development. 25, 26 When aneurysm lesions of the same grade were compared, EP4 Ϫ/Ϫ /LDLR Ϫ/Ϫ mice had greater MMP and cathepsin elastolytic activities than EP4 ϩ/ϩ /LDLR Ϫ/Ϫ mice, as determined by in situ zymography using DQ-elastin as a substrate. This observation could result from the more numerous macrophages residing within the EP4 Ϫ/Ϫ /LDLR Ϫ/Ϫ aneurysm lesions, or EP4 may directly influence the expression of proteolytic activities. Under some conditions, PGE 2 may augment MMP-9 production in macrophages in an EP4-dependent manner. 18 Conversely, PGE 2 may decrease MMP-9 through EP4. 19 The former study performed experiments on resting macrophages obtained from thioglycollate-elicited peritoneal macrophages in mice, whereas the latter study used peritoneal macrophages from human patients with endometriosis. The experimental settlings of the 2 studies differed greatly, and the cause of the discrepancy remains unknown. The present in vivo and in situ results support the latter observation and suggest that EP4deficient bone marrow-derived cells enhance the ability of MMP and cathepsins to break down elastin within the aneurysm lesions.
Targeted disruption of the gene for cyclooxygenase-2 or mPGES-1 exhibited cardioprotective effects, depressing PGE 2 production and retarding AAA formation. 7, 27 Thus, EP ligands derived from cyclooxygenase-2 and mPGES-1 pro- Lesions that lack EP4 emit greater fluorescence, representing greater elastolytic activities. All images were obtained using the same bright field, shutter speed, and magnification. MMP activity was determined at pH 7.4 (with E64 to inhibit cathepsin activities), and cathepsin activity was determined at pH 5.5 (with EDTA to inhibit MMP activities). These conditions allow optimal activity for the respective enzymes. Negative controls (EDTA and E64) were added to MMP and cathepsin measurements, respectively; and no-substrate controls (data not shown, fluorescence emission negligible) were performed in parallel sections on the same slides for all experiments. Fluorescence intensity (FI), as measured using computer-assisted image quantification, is expressed in percentage of fluorescence area over aneurysm lesion area on each crosssection, excluding the media area due to medial elastin filament autofluorescence. MeanϮSD FIs (percentage of aneurysm lesion area) are indicated on the image (nϭ3-4).
mote AAA pathogenesis. The specific responsible EP receptor remains undefined, but activation of EP4 does not likely explain this result. As demonstrated herein, EP4 reduces the incidence and severity of AAA. Because of the existence of multiple EP receptors and the opposing effect each one may deliver, selective inhibitors (or agonists, as in the case of EP4) for individual EP receptors may provide a more attractive option than upstream inhibition of cyclooxygenase or mPGES-1 in the treatment or prevention of AAA.
Male and female EP4 ϩ/ϩ /LDLR Ϫ/Ϫ mice exhibited 50% and 22% incidence of AAA formation, respectively; these rates were lower than those reported in previous studies 7, 28, 29 using the same technique to induce aneurysms. Furthermore, the AAAs had lower grades than previously reported. In our study, all recipient mice underwent irradiation for bone marrow transplantation, which may retard AAA development. In our pilot study, in which nonirradiated LDLR Ϫ/Ϫ mice served as recipient mice to determine the required dose of Ang II for aneurysm generation, 100% (4 of 4) of the mice infused with 1000-ng/kg per minute of Ang II developed type 3 or 4 AAAs. PGE 2 did not suppress chemokine expression in human endothelial cells and SMCs treated with lipopolysaccharide and proinflammatory cytokines (in contrast with macrophages), 12 and such findings justify the rationale for examining EP4 specifically in bone marrow-derived cells in our study. EP4 Ϫ/Ϫ mice do not survive in the congenic C57BL/6 strain; most die soon after birth because of ineffective closure of the ductus arteriosus. 30 Breeding on a mixed-strain background increases survival of EP4-deficient mice. Thus, bone marrow transplantation was performed using bone marrow cells from mice of a mixed background (129/Olac, C57BL/6, and DBA/2). Presumably, the mixed genetic background offers alleles that provide alternative mechanisms for ductal closure. 30 All bone marrow transplantations in our study used EP4 Ϫ/Ϫ mice and their wild-type littermates of the same mixed background. Therefore, any observed differences between experimental groups do not result from the bone marrow transplantation mismatch.
It is generally understood, 31 and apparent in EP4 ϩ/ϩ / LDLR Ϫ/Ϫ mice, that male mice have greater susceptibility to AAA formation than female mice; interestingly, the incidence of AAA appeared to be equal between the male and female EP4 Ϫ/Ϫ /LDLR Ϫ/Ϫ recipients in our study. In addition, AAA lesional sections from male and female EP4 ϩ/ϩ /LDLR Ϫ/Ϫ mice have similar levels of mac-3 (a marker for macrophages) and CD4 (a marker for T cells). However, in EP4 Ϫ/Ϫ / LDLR Ϫ/Ϫ mice, mac-3 and CD4 staining appeared greater in male than in female mice. The mRNA expression data agree with these histological data. These observations suggest that the differences in AAA incidence between the sexes could relate to the presence of EP4 on bone marrow-derived cells and differences in recruitment of leukocytes into aneurysmal lesions. Androgen is a primary cause for the enhanced propensity of Ang II-induced AAA in male mice because it increases the Ang II type 1A receptor. 32 Similarly, castration has decreased Ang II type 1A receptor abundance in mouse abdominal aortas and prevented AAA formation, whereas administration of dihydrotesterone increases Ang II type 1A receptor expression and promotes AAA incidence in castrated male and female mice. 33 Although androgen is one of the primary mediators driving sex differences in Ang II-induced AAA, this does not exclude a role for EP4 in sex differences in Ang II-induced AAA. The expression of EP4 seems subject to regulation by androgen and progesterone in different cell types. 34 -36 Furthermore, PGE 2 may regulate the activity of aromatase enzyme (a key enzyme that converts testerosterone into estradiol). 37, 38 Judging from these observations, EP4 may contribute to steriodogenesis and circui- tously influence AAA prevalence in Ang II-induced AAA mouse models through hormonal regulation.
During harvesting of the aorta for analysis, EP4 ϩ/ϩ / LDLR Ϫ/Ϫ mice and EP4 Ϫ/Ϫ /LDLR Ϫ/Ϫ mice exhibited unanticipated differences in the degree of lipid deposits on the thoracic aorta. Thus, we stained these lipids with oil red O to quantify the differences. Indeed, aortas of EP4 Ϫ/Ϫ /LDLR Ϫ/Ϫ mice had significantly more lipids en face. Profiling plasma for lipids revealed higher triglycerides and total cholesterol in EP4 Ϫ/Ϫ /LDLR Ϫ/Ϫ mice than in EP4 ϩ/ϩ /LDLR Ϫ/Ϫ mice. The differences in plasma cholesterol and triglycerides between wild-type mice and knockout chimeric mice only occur with Ang II administration. Thus, EP4 contributes to Ang II regulation of lipid metabolism. Ang II modulates lipid metabolism at many levels: it can affect cellular lipid peroxidation, increase cellular oxidized LDL uptake by macrophages (via lectin-like receptor for oxidized LDL), alter insulin sensitivity, affect adipocyte differentiation, and inhibit lipolysis in adipose tissues. Resolution of the involvement of EP4 in these Ang II-dependent pathways is beyond the scope of the present study and is a task for future research.
Hyperlipidemia in EP4 Ϫ/Ϫ /LDLR Ϫ/Ϫ mice complicates the interpretation of this study. There are 2 possible explanations for the enhanced AAA formation in EP4 Ϫ/Ϫ /LDLR Ϫ/Ϫ mice: (1) the lack of EP4 on bone marrow cells results in greater local inflammation, and (2) the lack of EP4 on bone marrow cells results in the elevation of plasma lipids. The present study cannot discriminate between the impact of altered lipid metabolism and the role of local inflammatory changes on AAA development in EP4 Ϫ/Ϫ /LDLR Ϫ/Ϫ mice. Changes in AAA incidence or severity and characteristics in EP4 Ϫ/Ϫ / LDLR Ϫ/Ϫ mice may result from both mechanisms. We cannot conclude that the enhancement of AAA formation results solely from the anti-inflammatory role of EP4, but several observations support this hypothesis: (1) The overall comparison, in which all grades of aneurysmal lesions were included in the analysis, revealed greater protein expression of MCP-1, macrophages, and T cells in aneurysmal lesions of EP4 Ϫ/Ϫ /LDLR Ϫ/Ϫ mice, indicative of an increase in localized inflammation. (2) In an analysis of aneurysm lesions of the same grade among groups, the amounts of MCP-1 and inflammatory cells (macrophages and T cells) were increased in sections derived from EP4 Ϫ/Ϫ /LDLR Ϫ/Ϫ mice, despite the small sample size. (3) In RT-PCR experiments using suprarenal sections of the aorta in which aneurysms occurred (from all mice regardless of AAA type), the mRNA levels of CD3, CD68, and MCP-1 were increased in aortas of both male and female EP4 Ϫ/Ϫ /LDLR Ϫ/Ϫ mice. (4) When aneurysms of the same grade among groups were compared, the mRNA levels of CD3, CD68, and MCP-1 remained significantly higher in aortas of EP4 Ϫ/Ϫ /LDLR Ϫ/Ϫ mice compared with EP4 ϩ/ϩ / LDLR Ϫ/Ϫ mice, despite the small sample size. These observations collectively support a role of EP4 in suppressing localized inflammation in aneurysm lesions. In addition, it was previously demonstrated that PGE 2 suppresses macrophage-derived chemokine production via EP4 in vitro. 12 In lipopolysaccharide-treated human macrophages, PGE 2 attenuated lipopolysaccharide-induced mRNA and protein expression of chemokines, including MCP-1, IL-8, MIP-1␣, MIP-1␤, and inducible protein-10. A selective EP4 antagonist completely reversed PGE 2 -mediated suppression of chemokine production. PGE 2 also inhibited tumor necrosis factor-␣-, interferon-␥-, and IL-1␤-mediated expression of these chemokines. 12 These in vitro data strengthen the idea that the greater AAA formation in EP4 Ϫ/Ϫ /LDLR Ϫ/Ϫ mice results from greater local inflammation. The possibility that EP4 may modulate lipids is intriguing and opens an exciting field of future research. Few studies have explored the role of EP4 in lipid metabolism. Reports 39, 40 have suggested that activation of EP4 suppresses food intake in mice, and in vitro studies 41 have suggested that EP4 suppresses adipocyte differentiation. Mechanisms that underlie these effects remain unexplored.
In conclusion, this study shows that the absence of EP4 on bone marrow-derived cells dramatically increases AAA formation induced by infusion of Ang II in hyperlipidemic mice. The lack of EP4 on bone marrow cells increased MCP-1 expression, infiltration of macrophages and T cells, elastin fragmentation, apoptosis, and MMP and cathepsin elastolytic activity and decreased SMC density within the aneurysmal lesions. Our data support the importance of EP4 on bone marrow cells in suppressing local inflammation during the pathogenesis of experimental aneurysm.
